Low-dose combination oral contraceptives use in women with uterine leiomyomas;Miomi uterini e contraccettivi orali a basso dosaggio

Minerva Ginecologica

Volumn 54, Issue 3, 2002, Pages 253-261

  Orsini, G ^a   Laricchia, L ^b   Fanelli, M ^a  

^a UNIVERSITY OF BARI   (Italy)

^b Ospedale Policlinico Consorziale ^*

Author keywords

Contraceptives, oral; Hematocrit; Leiomyom, diagnosis; Menstruation; Uterine neoplasms

Indexed keywords

DESOGESTREL; ETHINYLESTRADIOL; GESTODENE; ORAL CONTRACEPTIVE AGENT;

ARTICLE; CLINICAL TRIAL; DRUG EFFECT; FEMALE; FOLLOW UP; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MENSTRUATION; ORAL CONTRACEPTION; UTERUS MYOMA;

ADULT; CHI-SQUARE DISTRIBUTION; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, SYNTHETIC; DATA INTERPRETATION, STATISTICAL; DESOGESTREL; ESTRADIOL CONGENERS; ETHINYL ESTRADIOL; FEMALE; FOLLOW-UP STUDIES; HEMATOCRIT; HUMANS; LEIOMYOMA; MENSTRUATION; MIDDLE AGED; NORPREGNENES; PROGESTERONE CONGENERS; PROSPECTIVE STUDIES; TIME FACTORS; UTERINE NEOPLASMS; UTERUS;

EID: 0036070401     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomioma volume by magnetic resonance imaging: A prospective, randomised, double blind, placebo-controlled, crossover trial
2. Health during prolonged use of levonorgestrel 20 μg/d and the copper TCu 380Ag intrauterine contraceptive devices: A multicenter study
3. Progesterone: A critical role in the pathogenesis of uterine myomas
4. Fibroid growth in response to high-dose progesteron
5. Add-back therapy for long-term use in dysfunctional uterine bleeding and uterine fibroids
6. Increased expression of Bcl-2 protein in human uterine leiomyoma and its upregulation by progesteron
7. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata
8. Risk factors for uterine fibroids: Reduced risk associated with oral contraceptives
9. Oral contraceptive use and risk of uterine fibroids
10. Does low-dose combination oral contraceptive use affect uterine size or menstrual flow in premenopausal women with leiomyomas?
11. Use of oral contraceptives and uterine fibroids: Results from a case control study
12. Reduction in the size of a uterine leiomyoma following discontinuation of an estrogen-progestin contraceptive
13. Prise en charge des fibromes utérins: Contraception, THS et myomes
14. Insulin-like growth factor (IGF), IGF binding protein (IGFBP) and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata
15. Comportamento recettoriale dei fibroleiomiomi uterini in condizioni basali e in risposta alla terapia medica